Marcela
Marcela Bicalho, Dryden, NY US
Patent application number | Description | Published |
---|---|---|
20150335725 | VACCINE FOR INTRAUTERINE DISEASE - Provided are compositions and methods for use in prophylaxis of puerperal metritis and improving reproductive function of ruminants. The methods and compositions are for subcutaneous administration and are provided as veterinary compositions and as articles of manufacture. The veterinary composition can contain whole cells selected from whole cells of | 11-26-2015 |
Marcela De Castro Esteves, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090030946 | Indication-dependent control elements - A method is disclosed for controlling the display of activation elements for tools for editing medical data on a user interface in a computer-based, medico-technical system. In at least one embodiment, the activation elements are displayed in an activation element area, divided into various segments, of the user interface on the basis of the medical context. The doctor is thus able to select the tools clearly on a task- or indication-specific basis without an image data area of the user interface being concealed by the activation elements. | 01-29-2009 |
Marcela Del Carmen, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20150080847 | MEDICAMENT, METHOD, AND DRUG DELIVERY DEVICE FOR TREATMENT OF OVARIAN CANCER - Drug delivery devices, medicaments, and methods are provided for the intraperitoneal treatment of ovarian cancer. An implantable device for drug delivery includes an elongated, flexible device having a housing defining a reservoir that contains a drug in solid or semi-solid form, and configured to be wholly deployed within the peritoneal cavity of a patient and continuously release a therapeutically effective amount of the drug over a period of at least 24 hours. A medicament includes cisplatin for administration into the peritoneal cavity of a patient continuously over a treatment period of at least 24 hours. A method of drug delivery includes implanting within the peritoneal cavity of a patient an elongated, flexible device having a reservoir containing a drug, solubilizing the drug at least in part with peritoneal fluid, and releasing an effective amount of the solubilized drug from the reservoir continuously for a period of at least 24 hours. | 03-19-2015 |
Marcela De Leon Gatti, Arlington Heights, IL US
Patent application number | Description | Published |
---|---|---|
20100056766 | PURIFICATION OF BIOLOGICAL CONJUGATES BY SIZE EXCLUSION CHROMATOGRAPHY - A method for separating a biological conjugate from an aggregate. The molecular weight of the biological conjugate ranges from about 10 kDa to about 1000 kDa. In one embodiment, the method comprises the steps of: | 03-04-2010 |
20140066605 | PURIFICATION OF BIOLOGICAL CONJUGATES BY SIZE EXCLUSION CHROMATOGRAPHY - A method for separating a biological conjugate from an aggregate. The molecular weight of the biological conjugate ranges from about 10 kDa to about 1000 kDa. In one embodiment, the method comprises the steps of: | 03-06-2014 |
Marcela Del Rio Nechaevsky, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100040665 | METHOD FOR OBTAINING THREE-DIMENSIONAL STRUCTURES FOR TISSUE ENGINEERING - The present invention belongs to the field of tissue engineering and specifically relates to a method for obtaining three-dimensional structures for tissue engineering and to the structures obtained by said method. The invention also relates to an ex vivo method for regenerating a tissue using the three-dimensional structures of the invention and to the use of the structures thus treated for their transplanting to the area to be regenerated of the patient. | 02-18-2010 |
20120183505 | ARTIFICIAL DERMIS AND METHOD OF PREPARATION - Artificial dermis ( | 07-19-2012 |
20120208211 | HUMANISED PSORIASIS MODEL - The present invention relates to a new humanised animal model of psoriasis. Said model is generated by grafting humanised skin equivalents in the animal, injecting T lymphocytes and cytokines involved in the generation of the disease in humans, and performing the tape-stripping technique in order to generate damage in said grafted equivalents. Said model may be used to study the disease, as well as for the identification and evaluation of the efficacy of compounds against said disease. | 08-16-2012 |
Marcela Fernandez Michel, Zapopan MX
Patent application number | Description | Published |
---|---|---|
20140360423 | GAUGE HAVING VARIABLE DISPLAY - A gauge which uses a prism or other type of reflector to illuminate a single graphic or icon on a dial such that only one graphic on the dial is shown during the operation of the gauge. All of the remaining graphics have a dead front appearance, and cannot be viewed, such that the gauge presents only one discrete value at a time. The dial is beneath a lens, and the prism is beneath the dial. An actuator is mounted to a PCB, and an LED is also mounted to the PCB to allow the prism to transmit light to the desired area of the dial. The dial also includes a central graphic, or icon, and the gauge is able to display different values, while the central graphic remains constantly illuminated in the center of the gauge. | 12-11-2014 |
Marcela Garcia-Ramirez, Tampico MX
Patent application number | Description | Published |
---|---|---|
20100311907 | POLYMER COMPOSITION WITH ELASTOMERIC PROPERTIES AT WIDE TEMPERATURE RANGES AND PROCESS FOR THE PREPARATION THEREOF - It is depicted a polymer composition with elastomeric properties at wide temperature ranges of the type comprising polymers and/copolymers resulting from substituted or unsubstituted vinyl aromatic monomers and from dienic monomers, which is homogeneous and compatible in nature, with such composition being based on stereoregular polymers and without requiring the additional use of compatibilizing agents. Likewise, it is depicted the process to obtain the same, as well as to hydrogenise them, without requiring the use of additional catalyzers or processes. | 12-09-2010 |
Marcela Goeghova, Bratislava SK
Patent application number | Description | Published |
---|---|---|
20120004105 | HERBICIDAL COMPOSITIONS - Herbicidal compositions containing as active ingredients spiroheterocyclic pyrrolidine dione compounds. | 01-05-2012 |
Marcela Gonzalez Molezzi, Wauwatosa, WI US
Patent application number | Description | Published |
---|---|---|
20110208046 | SYSTEM AND METHOD TO ADAPTIVELY CONTROL CONTRAST-ENHANCED DIAGNOSTIC IMAGING PROCEDURE - A system and method are provided for determining individualized scan and injection protocols for contrast-enhanced diagnostic imaging. Taking into account parameters specific to the scan subject, injection-related parameters, and scan parameters, the system and method can determine an optimal timing for a scan sequence to begin, to ensure that the scan sequence coincides with a desired contrast enhancement. Some embodiments further provide for real-time triggering of the scan commencement based on bolus tracking, and can adapt the scan and injection protocols in real-time based on monitored dynamic scan subject parameters and/or actual enhancement values determined from image data. | 08-25-2011 |
Marcela Haberlova, Linz AT
Patent application number | Description | Published |
---|---|---|
20110114762 | FUEL INJECTOR HAVING A HIGH-PRESSURE INLET - The invention relates to a fuel injector for the operation of an internal combustion engine, having an injector body. An inlet bore of the injector body connects a conical pressure connection to a valve chamber for supplying highly pressurized fuel. The valve chamber is placed along a longitudinal center axis of the injector body and above a nozzle needle. According to the invention, the inlet bore further has a fan-shaped contour starting at the conical pressure connection along the extension thereof, the contour having a fan angle and a variable cross-section in the shape similar to an elongated hole. | 05-19-2011 |
Marcela Karpuj, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110311533 | REGULATION OF PROTEIN LEVEL - The invention relates to regulating the level of a membrane-anchored target molecule using PrP or a fragment thereof and a polyanion. Direct or indirect methods for targeting protein downregulation, mediated through PrP or a fragment thereof and a polyanionare are described. | 12-22-2011 |
Marcela Krecmerova, Praha CZ
Patent application number | Description | Published |
---|---|---|
20090005346 | Azacytosine Derivatives Useful as Antiviral Agents - The present invention provides 5-azacytosine derivatives with antiviral activity, specifically having viral replication inhibiting properties, more particularly in DNA viruses such as pox-, papilloma- and herpes viruses in humans. The invention also provides pharmaceutical compositions comprising such 5-azacytosine derivatives as active ingredients in combination with pharmaceutically acceptable carriers, which are useful for the treatment of subjects suffering from viral infections. | 01-01-2009 |
Marcela Miyazawa, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20090112871 | Genome sharing - Sharing data is disclosed. In some cases, sharing data includes receiving a request to share data from a first account to a second account, receiving an indication of a plurality of first account profiles associated with the first account to share with the second account, and establishing sharing from the plurality of first account profiles to the second account, wherein sharing comprises the second account having read access to a subset of nonpublic data associated with the plurality of first account profiles. | 04-30-2009 |
Marcela Munzarova, Zelezny Brod CZ
Patent application number | Description | Published |
---|---|---|
20140026897 | FACE MASK AND METHOD OF ITS PRODUCTION - The present disclosure relates to a face mask for removal of biological and mechanical impurities from breathed and/or exhaled air, comprising an inner textile layer and an outer textile layer, between which there is arranged a filtering layer of polymer nanofibres and/or active layer of polymer nanofibres, which in its structure contains a biocidal substance/s. The outer as well as the inner textile layer are formed of microfibres, while at least the outer textile layer and with it neighbouring filtering or active layer of polymer nanofibres are hydrophobic, and all layers are interconnected by a net of joints, that prevent their mutual motion and reduce permeability of the face mask only minimally. The inner textile layer is on periphery of the face mask provided with a layer of an adhesive for fastening to the face of the user. This method of fixing the face mask to the face secures perfect adhesion of the face mask to the skin along its entire periphery, thus preventing breathing of an unfiltered air. | 01-30-2014 |
Marcela Nechaevsky Del Rio, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090070889 | MOUSE MODEL COMPRISING AN ENGRAFTED HUMAN SKIN HAVING HYPERSENSITIVITY TO UV-LIGHT - The present invention relates to a humanized, non-human mammal model, preferably a humanized mouse model, with an engrafted portion of human skin having hyper-patient sensitivity to ultra violet (UV) light, and a method for preparing such non-human mammal model and its use for studying acute and long term effects on human skin by exposure to UV light and for testing topically or systematically applied or administered substances for their capability to prevent, repair and/or cure damages of such exposed human skin. This mouse model comprises an engrafted portion of human skin based on skin cells of a human Xeroderma pigmentosum (XP) or Gorlin's Syndrome (GS) patient. XP and GS are rare human autosomal disorders characterized clinically by hypersensitivity to UV light, especially to UVB rays, and high predisposition for developing skin cancers on sunlight exposed skin areas. | 03-12-2009 |
Marcela Ridao Dalmau, Llica D'Amunt ( Barcelona ) ES
Patent application number | Description | Published |
---|---|---|
20160015487 | ONE-PIECE DENTAL IMPLANT FOR DIRECT CONNECTION TO A PROSTHESIS - Dental implant of the type formed by a single body, having an implant section intended for introduction into the maxillary bone and provided with a self-tapping screw, and a receiving section that comprises a troncoconical surface intended to receive directly a temporary or permanent dental prosthesis, the said implant also having an axial orifice with a thread for receiving a retaining screw, as well as a polygonal prismatic section intended for the tightening of the implant for its implantation in the bone, characterised in that the conical section is immediately adjacent to the implant section, without the intermediation of the polygonal prismatic section. | 01-21-2016 |
Marcela Simková, Brno SK
Patent application number | Description | Published |
---|---|---|
20150234966 | METHOD AND AN APPARATUS FOR AUTOMATIC GENERATION OF VERIFICATION ENVIRONMENT FOR PROCESSOR DESIGN AND VERIFICATION - A method and a system embodying the method for automatic generation of a verification environment, comprising providing a first model of an application-specific instruction-set processor; providing a second model of the application-specific instruction-set processor; and generating automatically the verification environment from the first model and the second model is disclosed. | 08-20-2015 |
Marcela Simsova, Vostec CZ
Patent application number | Description | Published |
---|---|---|
20090317854 | Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase - Diagnostic testing and immunomonitoring that uses genetically detoxified | 12-24-2009 |
Marcela Vera-Garcia, Framingham, MA US
Patent application number | Description | Published |
---|---|---|
20080240985 | Nucleic Acid Assays - The present invention relates to the detection of specific nucleic acid sequences, either by a process of amplification of specific nucleic acid sequences or not. More particularly the invention provides for improved compositions and methods for reducing the chance for contamination from manipulation of reagents, internal controls for amplification, and the use of automated apparatus for the automated detection of one, or more than one amplified nucleic acid sequences. | 10-02-2008 |